Explainer · July 29, 2026 · 6 min · By Darius Engelhardt
Masseter Neurotoxin or Buccal Fat Removal: Two Very Different Fixes for a Wide Lower Face
Both procedures are marketed as face slimming, but they act on different tissues, carry different risks, and suit different anatomy. Here is how clinicians actually decide between them.

Search interest in lower face slimming has grown steadily, and two procedures dominate the conversation: masseter neurotoxin injections and buccal fat pad removal. They are frequently discussed as if they were interchangeable, which they are not. One works on muscle, one removes fat, and choosing the wrong one for your anatomy can produce disappointing or even aging results. This explainer walks through the mechanisms, the candidacy questions clinicians ask, and where the evidence currently sits.
Start with what is actually making the face wide. The lower third of the face gets its shape from four layers: bone, muscle, fat, and skin. A wide or square lower face can come from a naturally broad mandibular angle, from hypertrophy of the masseter muscle, from a prominent buccal fat pad, or from some combination. Palpation is the standard first test. When a patient clenches their teeth, an injector can feel the masseter bulge at the angle of the jaw. If that bulge is substantial and softens when the jaw relaxes, muscle is a major contributor. If the fullness sits more forward, in the mid cheek below the cheekbone, and does not change with clenching, the buccal fat pad is the more likely culprit.
How masseter neurotoxin works. Botulinum toxin blocks acetylcholine release at the neuromuscular junction, temporarily weakening the treated muscle. With repeated dosing over months, the masseter undergoes partial disuse atrophy and physically shrinks. Imaging studies using ultrasound have documented measurable reductions in masseter thickness, typically becoming visible around four to eight weeks after treatment. The effect is reversible: if injections stop, the muscle gradually recovers bulk over roughly six to twelve months. Typical dosing runs from 20 to 50 units per side depending on the product and muscle size, repeated every four to six months initially, then less often as the muscle deconditions. A secondary benefit reported in the literature is reduced bruxism and jaw clenching symptoms, which is why some patients pursue the treatment for function rather than aesthetics.
How buccal fat removal works. The buccal fat pad, sometimes called the fat pad of Bichat, is a discrete encapsulated fat structure sitting deep in the cheek between the buccinator and masseter muscles. Surgical removal is performed through a small incision inside the mouth, extracting a portion of the pad, usually a few cubic centimeters. The result is a subtle hollowing of the mid to lower cheek that accentuates the shadow beneath the cheekbone. Unlike neurotoxin, this is permanent. The pad does not regenerate, and it also does not behave like ordinary subcutaneous fat, meaning weight changes affect it less than surrounding tissue.
The permanence is the point of caution. Facial fat compartments deflate with age. The buccal region naturally thins in most people through their forties and fifties. Removing buccal fat from a young patient with an already lean face can look striking at 25 and gaunt at 45, a concern that surgical societies and individual surgeons have raised repeatedly as the procedure trended on social media. Conservative removal, or declining the procedure entirely in thin faced patients, is the mainstream position. Neurotoxin carries no equivalent long term deflation risk because its effect fades, though its recurring cost adds up.
Risk profiles differ in kind, not just degree. Masseter injections are low risk when placed correctly, but known complications include a temporary asymmetric smile if toxin diffuses into the risorius or zygomaticus muscles, chewing fatigue in the first weeks, and rarely a paradoxical bulge from uneven muscle weakening. Buccal fat removal is a true surgery near the parotid duct and buccal branches of the facial nerve, so complications, while uncommon in experienced hands, can include duct injury, hematoma, infection, asymmetry, and nerve related weakness. Recovery involves several days of swelling and an intraoral incision that must heal in a bacteria rich environment.
Who suits which procedure. The strongest masseter candidates have palpable muscle hypertrophy, often with a history of clenching or grinding, and a lower face that widens at the jaw angle. The strongest buccal fat candidates are adults with genuinely full mid cheeks that persist at a stable healthy weight, ideally with rounder facial structure that can afford some volume loss over decades. Patients whose width comes from the mandible itself will get limited benefit from either and are sometimes better served by a conversation about skeletal contouring or simply realistic expectations.
The bottom line. These are complementary tools aimed at different tissues, not competing versions of the same fix. A careful clinical exam, including a clench test and an honest discussion of how faces thin with age, should drive the decision. If a consultation skips the anatomy and jumps straight to booking, that is a reasonable signal to seek a second opinion.
More in Explainer
View all →- Masseter Botox vs. Buccal Fat Removal: Two Very Different Routes to a Slimmer Lower Face
- Buccal Fat Removal: Why the Same Procedure Slims One Face and Ages Another
- Masseter Botox for Jawline Slimming: What the Muscle Actually Does, and Who It Helps
- Masseter Botox vs. Buccal Fat Removal: Two Very Different Roads to a Slimmer Lower Face